AI assistant
Sending…
IONIS PHARMACEUTICALS INC — Director's Dealing 2011
Jul 29, 2011
30591_dirs_2011-07-29_5dc34188-9981-4ffa-a9d6-5663671b82e0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2011-07-28
Reporting Person: BENNETT C FRANK (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-07-28 | Common Stock | S | 1000 | $8.60 | Disposed | 305 | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/23/11.
More from IONIS PHARMACEUTICALS INC
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 24